German health care: A bit of Bismarck plus more science

BMJ

Volumn 337, Issue 7679, 2008, Pages 1142-1145

  Sawicki, Peter ^a   Bastian, Hilda ^a  

^a INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DRUG COST; DRUG USE; EVIDENCE BASED MEDICINE; GERMANY; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH STATUS; LAW; PATIENT RIGHT; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

GERMANY; HEALTH SERVICES ACCESSIBILITY; INSURANCE, HEALTH; STATE MEDICINE;

EID: 56749153072     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hennock EP. The origin of the welfare state in England and Germany, 1850-1914: social policies compared. Cambridge: Cambridge University Press, 2007.
2. Nowak D. Doctors on strike - the crisis in German health care delivery. N Engl Med 2006;355:1520-2.
3. Van der Zee J, Kroneman MW. Bismarck or Beveridge: a beauty contest between dinosaurs. BMC Health Serv Res 2007;7:94.
4. Irvine B, Green DG. Social insurance - the right way forward for health care in the United Kingdom? BMJ 2002;325:488-90.
5. Gemeinsame Bundesausschuss (Federal Joint Committee). The German health care system and the Federal Joint Committee. Bonn: GBA, 2007. www.g-ba.de/institution/sys/English.
6. Bundesministerium der Justiz. Sozialgesetzbuch (SGB) Fünftes Buch (V) - Gesetzliche Krankenversicherung. [Social law, 5th book, statutory health insurances] 2008. http://bundesrecht.juris.de/sgb_5.
7. Schoen C, Osborn R, Huynh PT, Doty M, Zapert K, Peugh J, et al. Taking the pulse of health care systems: experiences of patients with health problems in six countries. Health Aff (Millwood) 2005 Jul-Dec (suppl web exclusives):w5-509-25.
8. Organisation for Economic Cooperation and Development. OECD health data 2007. Paris: OECD, 2007.
9. Bramley-Harker E, Barham L. Comparing physicians' earnings: current knowledge and challenges: a final report for the Department of Health. London: NERA Economic Consulting, 2004. www.nera.com/image/ Report_Physician_Earnings_7.2005.pdf.
10. Organisation for Economic Cooperation and Development. Science and technology scoreboard 2007: health-related R&D. http://caliban. sourceoecd.org/vl=10224931/cl=-27/nw-1/rpsv/sti2007/a-8.htm.
11. Hauschild W, Klose A. [Cost structures for medical and dental practices 2003.] Berlin: Statistisches Bundesamt, 2006.
12. Deveugele M, Derese A, van den Brink-Muinen A, Bensing J, de Maeseneer J. Consultation length in general practice: cross sectional study in six European countries. BMJ 2002;325:472.
13. Danzon PM, Furukawa MF. International prices and availability of pharmaceuticals in 2005. Health Aff 2008;27:221-33.
14. Garattini L, Motterlini N, Cornago D. Prices and distribution margins of in-patent drugs in pharmacy: a comparison in seven European countries. Health Policy 2008;85:305-13.
15. Gemeinsamer Bundesausschuss. [Federal joint committee retains the prescribing restriction for clopidogrel under statutory health insurance.] Press release, 22 February 2008.
16. European Commission. Health in the European Union. Special Eurobarometer 272e/Wave 66.2. 2007. http://ec.europa.eu/health/ ph_publication/eb_health_en.pdf.
17. OECD. Health care quality indicators project 2006: data collection update report. www.oecd.org/dataoecd/57/22/39447928.pdf.
18. Veit C, Bauer J, Döbler K, Eckert O, Fischer B, Woldenga C. [BQS quality report 2006.] Düsseldorf: Bundesgeschäftsstelle Qualitätssicherung, 2007. www.bqs-qualitaetsreport.de/2006/ergebnisse/ leistungsbereiche/hueft_femur/ergebnisse/index_html.
19. Sawicki PT. [Quality of health care in Germany: a six country comparison.] Med Kiln 2005;100:755-68.
20. Forster R, Kranich C. [Patient and public involvement in health care - a comparison between recent English and German policies.] Gesundheitswesen 2007;69:98-104.
21. Dierks M-L, Seidel G, Schwartz FW, Horch K. [Public and patient orientation in the health care system.] Issue 32 Gesundheitsberichterstattung des Bundes. Benin: Robert Koch Institute, 2006.
22. Forum Gesundheitspolitik. [Every fourth self-help group is sponsored by drug companies.] www.forum-gesundheitspolitik.de/artikel/artikel.pl?artikel= 0555.
23. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002;325:746.
24. Lang FR, Wagner GG. [Patient living wills in Germany: conditions for their increase and reasons for refusal.] Dtsch Med Wochenschr 2007;132:2558-62.
25. Ministry for Health and Social Insurance, Ministry for Justice. [Patient rights in Germany: Guidelines for patients and doctors.] www.die- gesundheitsreform.de/gesundheitssystem/publikationen/pdf/ broschuere_patientenrechte_deutschland.pdf.
26. German Institute for Quality and Efficiency in Health Care. The institute. www.iqwig.de/about-us.21.en.html.
27. Perleth M, Busse R. Health technology assessment in Germany: status, challenges, and development. Int J Tech Assess in Health Care 2000;16:412-28.